These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 546748)

  • 21. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system depressant, analgesic and monoamine oxidase inhibitory properties of substituted piperidines.
    Pandey BR; Agrawal DK; Parmar SS; Willson WW; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Jan; 43(1):173-6. PubMed ID: 6701401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some new N-substituted alpha-aryl/alkyl succinimides as possible anticonvulsants.
    Amir M; Singh E
    Pharmazie; 1991 Oct; 46(10):705-7. PubMed ID: 1803384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer phenothiazines as anticonvulsants and monoamine oxidase inhibitors.
    Lata A; Satsangi RK; Srivastava VK
    Pharmazie; 1982 Aug; 37(8):549-51. PubMed ID: 7146060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 2-(4-arylthiosemicarbazidocarbonylthio)benzthiazoles and their monoamine oxidase inhibitory and anticonvulsant properties.
    Singh SP; Misra RS; Parmar SS; Brumleve SJ
    J Pharm Sci; 1975 Jul; 64(7):1245-7. PubMed ID: 1151692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel indolyl pyrazolines as monoamine oxidase inhibitors.
    Tripathi S; Pandey BR; Barthwal JP; Kishore K; Bhargava KP
    Indian J Physiol Pharmacol; 1980; 24(2):155-9. PubMed ID: 7380531
    [No Abstract]   [Full Text] [Related]  

  • 29. 2-(2'-Hydroxyphenyl)-4-aryl-1,5-benzodiazepines as CNS active agents.
    Srivastava VK; Satsangi RK; Kishore K
    Arzneimittelforschung; 1982; 32(12):1512-4. PubMed ID: 6891590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant activity and monoamine oxidase inhibitory properties of 1,3,5-trisubstituted pyrazolines.
    Parmar SS; Pandey BR; Dwivedi C; Harbison RD
    J Pharm Sci; 1974 Jul; 63(7):1152-5. PubMed ID: 4850598
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on the neuropharmacological actions of some newer substituted tetrazoles and quinazolones.
    Ahmad I; Shukla JS
    Indian J Physiol Pharmacol; 1982; 26(4):289-94. PubMed ID: 7152637
    [No Abstract]   [Full Text] [Related]  

  • 32. Search for newer substituted phenoxyacetylethyleneimines as possible CNS, MAO and anticonvulsant agents.
    Shukla JS; Ahmad I
    Pharmazie; 1981 May; 36(5):327-8. PubMed ID: 7267680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type B monoamine oxidase activity in human brain malignant tumors.
    Marcozzi G; Befani O; Mondovì B
    Cancer Biochem Biophys; 1998 Oct; 16(3):287-94. PubMed ID: 10072212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant and monoamine oxidase inhibitory properties of newer chlorostrylquinazolones.
    Misra RS; Chaturved AK; Rao NG; Parmar SS
    Pharmacol Res Commun; 1979 Jul; 11(7):623-33. PubMed ID: 504328
    [No Abstract]   [Full Text] [Related]  

  • 35. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
    Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
    J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of brain monoamine oxidase by 1,2,4-trisubstituted 5-imidazolones.
    Kumar S; Pandey BR; Parmar SS; Gallagher JR; Mayer GG
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):163-6. PubMed ID: 6729247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamine oxidase inhibitory coumarin from Zanthoxylum schinifolium.
    Jo YS; Huong DT; Bae K; Lee MK; Kim YH
    Planta Med; 2002 Jan; 68(1):84-5. PubMed ID: 11842339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between anti-inflammatory, antiproteolytic and antihemolytic properties of some newer substituted S-triazole-2-thiols.
    Parmar SS; Raman K; Kumar S; Brumleve SJ
    Proc West Pharmacol Soc; 1978; 21():223-7. PubMed ID: 693500
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.